EUVIMEDOpdag EUVIMED
LeitlinieÜbersichtsarbeitOpen access · CC BY 4.0

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

Simon M Mueller iD, Helmut Beltraminelli iD, Wolf-Henning Boehncke iD, Maximilian Böhm, Antonio Cozzio iD, Peter Häusermann, Ahmad Jalili, Antonios G A Kolios iD, Claudia Lang iD, Eva Loos iD, Christoph Schlapbach iD, Curdin Conrad iD

International Journal of Dermatology · 2026-12 · 65 (12) · 2497-2508

DOI: 10.1111/ijd.70533 ↗

At a glance

Leitlinie in International Journal of Dermatology, published online on 2026-06-18. Written by Simon M Mueller and 11 co-authors. Institution: Department of Dermatology, University Hospital Basel, Basel, Switzerland. Major MEDLINE topics: Prurigo, Dermatologic Agents. Cited 1 times so far (Crossref); 129 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Management of chronic prurigo (CPG), including prurigo nodularis (PN), is challenging due to its chronic, often treatment‐refractory course, high disease burden, and increasing complexity of therapies. International guidelines are partly outdated and may not fully reflect country‐specific considerations. Our aim was to develop practice recommendations for the diagnosis and treatment of CPG. Twelve hospital‐ and practice‐based experts formulated recommendations following a standardized literature review and structured expert consensus process, with recommendations voted on until ≥ 75% agreement was reached. Recommendation levels were guided by the GRADE methodology but adapted to allow practical, differentiated guidance, including the additional “Can be considered” category. Recommendations address history taking, laboratory testing, biopsy, questionnaires, general measures, pharmacological and non‐pharmacological therapies. “We recommend” applies to topical corticosteroids, narrow‐band ultraviolet B (NB‐UVB), dupilumab, and nemolizumab; “We suggest” to topical calcineurin inhibitors, zinc oxide dressings, cryotherapy, intralesional corticosteroids, gabapentinoids, antidepressants, methotrexate, ciclosporin, μ‐opioid receptor antagonists, Janus kinase inhibitors, and cognitive behavioral techniques; and “Can be considered” to capsaicin, ultraviolet A1 (UVA1), psoralen plus ultraviolet A (PUVA), and sedating antihistamines for sleep. No recommendation could be made for azathioprine, non‐sedating antihistamines, κ‐opioid receptor agonists, retinoids, neurokinin‐1 receptor antagonists, thalidomide, or lenalidomide. These recommendations provide comprehensive, up‐to‐date guidance for CPG, supporting clinicians in Switzerland and internationally. image

Subjects

MeSH terms (MEDLINE)

PrurigoDermatologic AgentsHumansChronic DiseaseCalcineurin InhibitorsSwitzerlandAdrenal Cortex HormonesCryotherapyUltraviolet TherapyJanus Kinase InhibitorsAntibodies, Monoclonal, HumanizedAntidepressive AgentsPUVA Therapy

Author keywords

Swiss expertschronic prurigochronic prurituspractice recommendationsprurigo nodularis

Substances

Calcineurin InhibitorsAdrenal Cortex HormonesDermatologic AgentsdupilumabJanus Kinase InhibitorsAntibodies, Monoclonal, HumanizedAntidepressive Agents

Authors and institutions

  • Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.
  • Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
  • Division of Dermatology and Allergology, HOCH Health Ostschweiz, St Gallen, Switzerland.
  • Private Practice Basel, Basel, Switzerland.
  • Dermatology & Skin Care Clinic, Buochs, Switzerland.

ORCID profiles: Simon M Mueller, Helmut Beltraminelli, Wolf-Henning Boehncke, Antonio Cozzio, Antonios G A Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad

Cite

APA

Mueller, S. M., Beltraminelli, H., Boehncke, W. H., Böhm, M., Cozzio, A., Häusermann, P., Jalili, A., Kolios, A. G. A., Lang, C., Loos, E., Schlapbach, C., & Conrad, C. (2026). Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis. International Journal of Dermatology, 65(12), 2497-2508. https://doi.org/10.1111/ijd.70533

Vancouver

Mueller SM, Beltraminelli H, Boehncke WH, Böhm M, Cozzio A, Häusermann P, et al. Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis. International Journal of Dermatology. 2026;65(12):2497-2508. doi:10.1111/ijd.70533

BibTeX
@article{Mueller2026,
  author = {Mueller, Simon M and Beltraminelli, Helmut and Boehncke, Wolf-Henning and Böhm, Maximilian and Cozzio, Antonio and Häusermann, Peter and Jalili, Ahmad and Kolios, Antonios G A and Lang, Claudia and Loos, Eva and Schlapbach, Christoph and Conrad, Curdin},
  title = {Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis},
  journal = {International Journal of Dermatology},
  year = {2026},
  volume = {65},
  number = {12},
  pages = {2497--2508},
  doi = {10.1111/ijd.70533}
}
Start for free →